|
Status |
Public on Jul 01, 2012 |
Title |
NBL 7 cell line treated |
Sample type |
RNA |
|
|
Source name |
NBL cell line 7
|
Organism |
Homo sapiens |
Characteristics |
cell line: NBL agent: DAC and TSA combination gender: female mycn status: MYCN amplified
|
Treatment protocol |
untreated, daily change of culture medium; treated, 72 hours 30 nM DAC with addition of 25 nM TSA during the last 48 hours, daily refreshal of culture media containing drugs
|
Growth protocol |
cultured in DMEM or RPMI at 37 C and 5% CO2 in non-hypoxic conditions
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol extraction of total RNA was performed according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).
|
|
|
Hybridization protocol |
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix HGU 133 Plus2.0 arrays. GeneChips were washed and stained according to Affymetrix protocol
|
Scan protocol |
GeneChips were scanned using the Affymetrix GeneChip® Scanner 3000 7G
|
Description |
Gene expression data of neuroblastoma cell line Sample name: NBL7_t KGK_IG_290307_NBL7_B.CHP KGK_IG_290307_NBL7_B.CEL
|
Data processing |
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling (TGT value 500) as normalization method.
|
|
|
Submission date |
Jan 19, 2012 |
Last update date |
Jul 01, 2012 |
Contact name |
Floor Duijkers |
Organization name |
Erasmus MC
|
Department |
Pediatric Oncology-Hematology
|
Street address |
Dr. Molewaterplein 50-60 Ee15-02
|
City |
Rotterdam |
ZIP/Postal code |
3015 GE |
Country |
Netherlands |
|
|
Platform ID |
GPL570 |
Series (2) |
GSE35218 |
Nanomolar treatment with epigenetic drug combination induces genome-wide methylation and expression alterations in neuro-ectodermal cell lines [mRNA] |
GSE35798 |
Nanomolar treatment with epigenetic drug combination induces genome-wide methylation and expression alterations in neuro-ectodermal cell lines |
|